In mouse models of PDAC, supplementation with melatonin can specifically increase the number of CD11b+Ly6G+ neutrophils that with high TNFα activity within the tumor, killing tumor cells via direct cell-to-cell contact mechanisms and thereby inhibiting tumor growth. This evidence concerns the gene TNF and neoplasm.